NewsSOS

Utah Medical Products revenue falls 14.3% in Q2 2026 as two former top customers book zero in sales

7/23/2026

Second-quarter revenues for Utah Medical Products, Inc.

(Nasdaq: UTMD) fell 14.3% to $8.529 million from $9.953 million a year earlier, the company disclosed Wednesday, with zero sales from two previously top accounts responsible for 75% of the shortfall.

The Salt Lake City medical device maker had planned to replace $2.889 million in annual lost revenue through new biopharma OEM customers; through the first half of 2026, those accounts generated only $211 thousand.

Revenue gap driven by two departed accounts PendoTECH, previously UTMD's largest domestic OEM customer for biopharma pressure monitoring devices and accessories, contributed $196 thousand in second-quarter 2025 domestic sales and zero in the same period this year.